Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
ST. LOUIS - Medical device maker Stereotaxis Inc. said Wednesday the Food and Drug Administration approved its new guidewire device for use in vascular surgery.
| STXS | 3.45 |  -0.01 |
The company's PowerAssert radiofrequency guidewire is used during vascular surgery, the goal of which is to unclog blocked arteries.
Stereotaxis is planning a limited introduction of the guidewire later this year, with a broader commercial launch to follow.
Shares of Stereotaxis rose 1 cent to $7 in afternoon trading.
The new chief executive of Royal Dutch Shell Plc faces the tallest order in Euro...
Cisco live 2009 website is down and nobody can access the site for the latest in...
|
Effective and Affordable Press Release Distribution Service
Come and experience the trading platform that everyone talks about. Simple, fast and exciting.
Take profit from the markets roller coaster. No downloads, no commissions, no spreads.
Partners  
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
